Melanoma BRAF Awareness Day is a new disease awareness day, developed in collaboration between Melanoma UK and Novartis UK, that will take place during Melanoma Awareness Month on 31st May 2021. It aims to:
Raise awareness and understanding of BRAF status: what it is, how you test for it and what it means for a patient’s diagnosis.
Support conversations between people with melanoma and their doctor.
Give people diagnosed with melanoma the confidence they need when talking to their healthcare team.
Empower patients with information to support them as an informed participant in their care pathway.
You can get involved in the campaign by downloading the logo...
... or the free virtual meeting backgrounds and joining the conversation on social media.
Introducing the SKINfluencers
What’s a SKINfluencer?
A SKINfluencer is a spokesperson who shares their expertise on melanoma and the importance of knowing your BRAF mutation status.
Anyone in the melanoma community can be a SKINfluencer. Share your support for the campaign and get involved on social media by using the hashtags: #MelanomaBRAFAwarenessDay #MelanomaAwarenessMonth #Melanoma #SkinCancer
Being diagnosed with skin cancer can be extremely worrying, a time of uncertainty and feeling overwhelmed. For many, little is known about the different types of skin cancer and the ways it can be treated.
Melanoma is the most serious form of skin cancer and the fifth most common cancer in the UK, with over 40 cases diagnosed every day.1 If detected early melanoma is almost always treatable.
Melanoma is a complex disease and multiple gene alterations have been found to play a role in its progression.
The three most common gene mutations in melanoma are BRAF, NRAS and c-KIT.2 Of these, the BRAF mutation is most common: around 40-50% of melanoma patients have it.3,4
There are treatments available that specifically target this type of mutation and a test to determine your BRAF status will be carried out by healthcare professionals when you are diagnosed. You should be told the result to help decide the best form of treatment.
How your BRAF mutation status is assessed
The melanoma patient journey will involve a team of dedicated healthcare professionals including GPs, dermatologists, nurses and more.5 One of the first tests undertaken in the early diagnosis stages will be a biopsy, which is a removal of the suspected melanoma cells on the skin. This can then be sent to a pathologist in a lab who will test for the specific gene mutation.